Skip to main content
. 2021 Sep 30;17:100275. doi: 10.1016/j.lanwpc.2021.100275

Table 3.

Frequency of medication dispensing/annum for sub-groups according to CTO status.

Category Medication On CTO Off CTO Rate ratio 95% CIs P-value
Male Antidepressant 5∙29 3∙20 1∙65 1.64-1.66 <0∙01
Anxiolytic 5∙22 2∙53 2∙06 2.05-2.08 <0∙01
Antipsychotic (depot) 6∙16 1∙74 3∙54 3.52-3.57 <0∙01
Antipsychotic (oral) 39∙07 15∙81 2∙47 2.46-2.48 <0∙01
Female Antidepressant 9∙08 6∙50 1∙40 1.39-1.41 <0∙01
Anxiolytic 7∙60 4∙21 1∙80 1.79-1.82 <0∙01
Antipsychotic (depot) 5∙40 1∙42 3∙80 3.76-3.84 <0∙01
Antipsychotic (oral) 46∙95 19∙79 2∙37 2.37-2.38 <0∙01
European/other Antidepressant 9∙32 6∙41 1∙45 1.45-1.46 <0∙01
Anxiolytic 8∙20 4∙51 1∙82 1.81-1.83 <0∙01
Antipsychotic (depot) 5∙72 1∙26 4∙54 4.50-4.59 <0∙01
Antipsychotic (oral) 43∙32 19∙34 2∙24 2.23-2.25 <0∙01
Māori Antidepressant 4∙26 2∙97 1∙43 1.42-1.45 <0∙01
Anxiolytic 4∙37 2∙40 1∙83 1.81-1.85 <0∙01
Antipsychotic (depot) 6∙25 2∙06 3∙03 3.01-3.07 <0∙01
Antipsychotic (oral) 43∙17 16∙98 2∙54 2.53-2.55 <0∙01
Pacifika Antidepressant 2∙65 1∙73 1∙53 1.50-1.57 <0∙01
Anxiolytic 2∙57 0∙99 2∙60 2.53-2.68 <0∙01
Antipsychotic (depot) 5∙44 2∙29 2∙37 2.33-2.42 <0∙01
Antipsychotic (oral) 32∙99 13∙75 2∙40 2.38-2.42 <0∙01
Asian Antidepressant 4∙01 2∙91 1∙38 1.34-1.42 <0∙01
Anxiolytic 3∙18 1∙00 3∙18 3.07-3.30 <0∙01
Antipsychotic (depot) 5∙98 0∙98 6∙10 5.91-6.29 <0∙01
Antipsychotic (oral) 31∙35 11∙22 2∙79 2.77-2.83 <0∙01
Psychotic Disorder Antidepressant 5∙82 3∙77 1∙54 1.53-1.55 <0∙01
Anxiolytic 6∙05 3∙05 1∙98 1.97-2.00 <0∙01
Antipsychotic (depot) 6∙15 2∙15 2∙86 2.83-2.88 <0∙01
Antipsychotic (oral) 43∙49 19∙45 2∙24 2.23-2.24 <0∙01
Non-Psychotic Disorder Antidepressant 8∙26 5∙57 1∙48 1.47-1.49 <0∙01
Anxiolytic 5∙99 3∙47 1∙73 1.71-1.75 <0∙01
Antipsychotic (depot) 5∙36 0∙96 5∙60 5.54-5.68 <0∙01
Antipsychotic (oral) 38∙06 15∙19 2∙50 2.50-2.51 <0∙01

P-value refers to the statistical comparison of the rate-ratios compared to 1.00